Product News: Chemical Processing & Waste Management

High-Performance Polyamides target mHealth electronic devices.

Share Like Tweet Add Email

Press Release Summary:

June 20, 2014 - Kalix® high-performance polyamides (HPPAs) – halogen-free Kalix HPPA 5000 series; bio-based, amorphous Kalix HPPA 3000 series; and bio-sourced, impact-resistant PPA grade Kalix 2000 series – are suited for structural components used in mobile healthcare (mHealth) electronic devices. Strength, stiffness, and chemical resistance properties specifically complement requirements of covers and housings for healthcare displays, terminals, and modules along with chassis, housings, and bezels.

Solvay Advanced Polymers, LLC

3702 Clanton Rd., Augusta, GA, 30916, USA

Original Press Release

Solvay Introduces Kalix® High-Performance Polyamides for Mobile Healthcare Electronic Devices

Press release date: June 11, 2014

Halogen-Free and Bio-Based Materials Deliver Strength, Stiffness, and Chemical Resistance for mHealth Covers and Housings

NEW YORK, N.Y. – Solvay Specialty Polymers has introduced a new family of Kalix® high-performance polyamides (HPPAs) for structural components used in mobile healthcare (mHealth) electronic devices. The new products, which include the Kalix® HPPA 5000 halogen-free series and bio-based Kalix® HPPAs, deliver exceptional strength, stiffness, and significantly improved chemical resistance versus traditional polycarbonate (PC) or PC/acrylonitrile-butadiene-styrene (ABS) materials typically used for covers and housings for mHealth electronic devices. Solvay made the announcement at the 2014 Medical Design & Manufacturing (MD&M) East exhibition June 10-12 in New York City.

The new Kalix® HPPAs – first launched for smart mobile electronics at K 2013 in Germany last October – are a unique offering targeted for frames and covers for healthcare displays, terminals, and modules along with chassis, housings, and bezels for mHealth devices.

"This material introduction strengthens our commitment to both the healthcare and mobile electronics industries,” said Maria Gallahue-Worl, global healthcare business manager for Solvay Specialty Polymers. “We’ve leveraged our extensive know-how in polymer technology and our long-term presence in healthcare to give our customers a competitive edge in meeting their end-use requirements.”

Kalix® 5950 HFFR’s high flow and low moisture absorption make it particularly suited for injection molding large structural components such as frames and covers for displays, terminals, and modules that require strength, rigidity, and exceptional dimensional stability.

Kalix® 5950 HFFR has received an Underwriters Laboratories (UL) 94 flammability rating of V0 for electrical/electronics applications for thicknesses of 0.4 mm and above and 5VA at thicknesses of 1.5 mm and above (both ratings are for all colors). The 50% glass fiber-reinforced grade provides greater mechanical properties than competing HFFR polyamides, and serves as an alternative to metals. Its exceptional mechanical properties include a tensile modulus of 20 GPa (2900 kpsi) and tensile strength of 250 MPa (36 ksi).

Solvay has also introduced a new portfolio of bio-based HPPAs for healthcare OEMs wanting to incorporate renewable, bio-based polymers for mHealth devices. This includes the Kalix® HPPA 3000 series, the first bio-based amorphous PPA, and the Kalix® 2000 series, a family of bio-sourced PPA grades that provide outstanding impact resistance. According to Gallahue-Worl, the company’s expanded portfolio of bio-based PAs is driven by environmentally-conscious medical manufacturers who are continually striving for more sustainable alternatives.

The Kalix® 3000 series breaks new ground as the industry’s first bio-based amorphous PPA. The two new grades – Kalix® 3850 and Kalix® 3950 – provide less warp, reduced shrinkage, and low to no flash. This improved processability results in tighter dimensional tolerances and more cost-effective manufacturing due to fewer secondary operations such as deflashing. Both compounded grades consist of 16% renewable content, according to the ASTM D6866 test method for determining bio-based carbon content.

Meanwhile, the new Kalix® 2000 series, based on PA 6,10, consists of Kalix® 2855 and Kalix® 2955. They provide strong mechanical properties, high impact strength, an exceptional surface finish, and low moisture absorption. These two compounded grades consist of 27% renewable content according to ASTM D6866.

Both the Kalix® 2000 and 3000 series contain monomers that come from the sebacic acid chain which is derived from non-food competing and GMO-free castor oil. Overall, in addition to their renewable content, the grades (between 50-55% glass fiber loading) provide greater strength and stiffness than most competing glass-reinforced materials including high-performance PAs and lower-performing engineering plastics such as PC.

Both the Kalix® 2000 and 3000 series offer an ultra-smooth surface finish. Along with Kalix® 5950 HFFR, they can be matched to a wide range of colors including the bright and light colors used for mHealth electronic devices. They can also be painted with existing coatings commonly used for these devices.

The new Kalix® HPPA materials are available globally and Solvay is currently seeking qualifications with leading manufacturers of mHealth electronic devices.

About Solvay Specialty Polymers

Solvay Specialty Polymers is a leading global supplier of high-performance thermoplastics for permanent and prolonged exposure implants and limited exposure devices. The company has expanded its focus on the healthcare industry to meet the growing needs of its global customers by providing global technical and regulatory support. Solvay is building on its 25-year history as a key material supplier in the healthcare field, devoting considerable new resources to help customers be more efficient and cut costs. Metal-to-plastic replacement remains a key focus for manufacturers, but increased cost pressures pose a new challenge as the market continues to grow at a double-digit pace. Solvay also continues to devote considerable research and development activities to polymer technology and commercialization of new and unique material options for medical OEMs and processors.

Solvay Specialty Polymers manufactures over 1500 products across 35 brands of high-performance polymers – fluoropolymers, fluoroelastomers, fluorinated fluids, semi-aromatic polyamides, sulfone polymers, aromatic ultra polymers, high-barrier polymers
and cross-linked high-performance compounds – for use in Aerospace, Alternative Energy, Automotive, Healthcare, Membranes, Oil & Gas, Packaging, Plumbing, Semiconductors, Wire and Cable, and other industries. Learn more at www.SolvaySpecialtyPolymers.com.

Solvay (www.solvay.com) is an international chemical Group committed to sustainable development with a clear focus on innovation and operational excellence. It is realizing over 90% of its sales in markets where it is among the top 3 global leaders. Solvay offers a broad range of products that contribute to improving quality of life and the performance of its customers in markets such as consumer goods, construction, automotive, energy, water and environment, and electronics. The Group is headquartered in Brussels and its companies, which employ about 29,400 people in 56 countries, generated EUR 9.9 billion in net sales in 2013 (pro forma). Solvay SA is listed as SOLB on NYSE Euronext (www.euronext.com) in Brussels and Paris. Bloomberg (www.bloomberg.com) = SOLB:BB and Reuters (www.reuters.com) = SOLB.BR.

Press Contact:
Joseph Grande
Media Relations
413.684.2463

Share Like Tweet Add Email

Comments

comments powered by Disqus